PKI 14-22 amide, myristoylated Acetate
This myristoylated PKI 14-22 amide acetate is a potent and cell-permeable inhibitor of cAMP-dependent protein kinase (PKA) . It effectively blocks PKA activity in vitro and inhibits hyperalgesia in vivo, as demonstrated by its ability to counteract pain sensitization induced by spinal 8-bromo-cAMP.
Product Specifications
Product Name Alternative
PKI 14 22 amide, myristoylated Acetate, PKI 1422 amide, myristoylated Acetate, PKI 14-22 amide, myristoylated Acetate, PKI 14-22 amide, myristoylated Acetate (201422-03-9 Free base), PKA
Field of Research
Signal Transduction
Purity
96.34% (May vary between batches)
Solubility
DMSO:55 mg/mL (43.32 mM)
Molecular Weight
1269.54
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog